Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 147

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 147
---
 common stock(2,900)(2,676)(2,316)Cash dividends(1,508)(1,395)(1,229)Proceeds from issuance of common stock under employee stock plans221 152 182 Taxes paid through withholding of common stock under employee stock plans(109)(99)(93)Other, net2 7 41 Net cash provided by (used in) financing activities1,193 (3,349)(1,318)Effect of foreign exchange rates on cash and cash equivalents(6)(1)(14)Change in cash and cash equivalents1,828 (861)2,507 Cash and cash equivalents at beginning of year6,526 7,387 4,880 Less cash and cash equivalents included in assets held for sale at end of year(66)— — Cash and cash equivalents at end of year$8,288 $6,526 $7,387 

See accompanying notes.

 -73-

Elevance Health, Inc.

Consolidated Statements of Shareholders’ EquityTotal Shareholders’ Equity Common StockAdditionalPaid-inCapitalAccumulatedOtherComprehensive(Loss) IncomeNoncontrolling InterestsTotalEquity(In millions)Numberof SharesParValueRetainedEarningsJanuary 1, 2022241.8 $2 $9,148 $27,119 $(197)$68 $36,140 Net income (loss)— — — 5,894 — (6)5,888 Other comprehensive loss— — — — (2,293)(11)(2,304)Noncontrolling interests adjustment— — — — — 36 36 Repurchase and retirement of common stock(4.8)— (184)(2,132)— — (2,316)Dividends and dividend equivalents— — — (1,234)— — (1,234)Issuance of common stock under employee stock plans, net of related tax benefits1.0 — 352 — — — 352 Convertible debenture repurchases and conversions— (232)— — — (232)December 31, 2022238.0 2 9,084 29,647 (2,490)87 36,330 Net income— — — 5,987 —